Neoglaucit en es it fr

Neoglaucit Brand names, Neoglaucit Analogs

Neoglaucit Brand Names Mixture

  • No information avaliable

Neoglaucit Chemical_Formula

C6H14FO3P

Neoglaucit RX_link

No information avaliable

Neoglaucit fda sheet

Neoglaucit msds (material safety sheet)

Neoglaucit MSDS

Neoglaucit Synthesis Reference

No information avaliable

Neoglaucit Molecular Weight

184.146 g/mol

Neoglaucit Melting Point

-82 oC

Neoglaucit H2O Solubility

1.54E+004 mg/L

Neoglaucit State

Liquid

Neoglaucit LogP

1.13

Neoglaucit Dosage Forms

No information avaliable

Neoglaucit Indication

For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.

Neoglaucit Pharmacology

Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.

Neoglaucit Absorption

No information avaliable

Neoglaucit side effects and Toxicity

Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.

Neoglaucit Patient Information

No information avaliable

Neoglaucit Organisms Affected

Humans and other mammals